Roivant Sciences Ltd
F:87S

Watchlist Manager
Roivant Sciences Ltd Logo
Roivant Sciences Ltd
F:87S
Watchlist
Price: 9.666 EUR 0.98%
Market Cap: 7.1B EUR
Have any thoughts about
Roivant Sciences Ltd?
Write Note

Wall Street
Price Targets

87S Price Targets Summary
Roivant Sciences Ltd

Wall Street analysts forecast 87S stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 87S is 15.208 EUR with a low forecast of 10.735 EUR and a high forecast of 20.46 EUR.

Lowest
Price Target
10.735 EUR
11% Upside
Average
Price Target
15.208 EUR
57% Upside
Highest
Price Target
20.46 EUR
112% Upside
Roivant Sciences Ltd Competitors:
Price Targets
BIOCON
Biocon Ltd
1% Downside
300406
Beijing Strong Biotechnologies Inc
68% Upside
ATYR
aTyr Pharma Inc
225% Upside
2256
Abbisko Cayman Ltd
23% Upside
DSGN
Design Therapeutics Inc
91% Upside
PRAX
Praxis Precision Medicines Inc
92% Upside
DVAX
Dynavax Technologies Corp
133% Upside

Revenue
Forecast

Revenue Estimate
Roivant Sciences Ltd

For the last 4 years the compound annual growth rate for Roivant Sciences Ltd's revenue is 5%. The projected CAGR for the next 3 years is 156%.

5%
Past Growth
156%
Estimated Growth
Estimates Accuracy
-39%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Roivant Sciences Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
Roivant Sciences Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 87S's stock price target?
Price Target
15.208 EUR

According to Wall Street analysts, the average 1-year price target for 87S is 15.208 EUR with a low forecast of 10.735 EUR and a high forecast of 20.46 EUR.

What is Roivant Sciences Ltd's Revenue forecast?
Projected CAGR
156%

For the last 4 years the compound annual growth rate for Roivant Sciences Ltd's revenue is 5%. The projected CAGR for the next 3 years is 156%.

Back to Top